• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2016 Fiscal Year Annual Research Report

Drug discovery platform for improvement of positive inotropic effect in septic myocardium

Research Project

Project/Area Number 15K15661
Research InstitutionNagoya University

Principal Investigator

松田 直之  名古屋大学, 医学系研究科, 教授 (50332466)

Co-Investigator(Kenkyū-buntansha) 服部 裕一  富山大学, 大学院医学薬学研究部(医学), 教授 (50156361)
Project Period (FY) 2015-04-01 – 2017-03-31
Keywords敗血症 / 心筋 / 細胞内情報伝達 / ホスホジエステラーゼ / G蛋白 / アデニール酸シクラーゼ
Outline of Annual Research Achievements

This study evaluated the alteration of cardiac beta-receptor signal using septic mouse model. We weighed the effects of dobutamine and milrinone as inotropes in BALB/c mice with cecal ligation and puncture (CLP)-induced sepsis. Surface expression levels of β1-adrenoceptors and alpha subunits of three main G protein families in myocardium were unaffected by CLP-induced sepsis. Plasma cyclic adenosine monophosphate (cAMP) levels were significantly elevated in both sham-operated and CLP mice in response to milrinone but only in sham-operated controls in response to dobutamine. Of phosphodiesterase (PDE) isoforms, PDE4D, but not PDE3A, both of which are responsible for cardiac cAMP hydrolysis, was significantly upregulated in CLP mouse myocardium.

  • Research Products

    (1 results)

All 2017

All Journal Article (1 results) (of which Peer Reviewed: 1 results,  Acknowledgement Compliant: 1 results)

  • [Journal Article] Diminished Responsiveness to Dobutamine as an Inotrope in Mice with Cecal Ligation and Puncture-Induced Sepsis: Attribution to Phosphodiesterase 4 Upregulation.2017

    • Author(s)
      Sakai M, Suzuki T, Tomita K, Yamashita S, Palikhe S, Hattori K, Yoshimura N, Matsuda N, Hattori Y.
    • Journal Title

      Am J Physiol Heart Circ Physiol

      Volume: 印刷中 Pages: 印刷中

    • DOI

      10.1152

    • Peer Reviewed / Acknowledgement Compliant

URL: 

Published: 2018-01-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi